Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

72293 1527666247HCLSReviewCanadaMay2018.pdf
Energy Boardroom

Specialty focus enables UCB to repel austerity

27.02.2014 / Scripintelligence

By focusing on specialty drugs for severe neurological and immunology disorders UCB CEO Roch Doliveux believes his company is positioned well to cope with payer pressures in the developed world while making major headway in key emerging markets. Indeed,…

LATEST ISSUE

DOWNLOAD

Most Read

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: